D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain

NCT00301080 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Funding for the study fell through.

Conditions

Neurotoxicity
Pain
Breast Cancer

Interventions

DRUG: D-cycloserine
OTHER: Placebo

Sponsor

Northwestern University